Chest Trauma Scoring Systems as Predictors of Morbidity and Mortality in Iraq
ConditionChest Injury Trauma Blunt
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. The primary questions it seeks to address are:
How accurately do chest trauma scoring systems predict mortality and critical outcomes such as ICU admission or the need for advanced interventions? How well do these scoring systems stratify patients based on injury severity in a resource-limited setting? Are there any demographic or clinical factors that impact the predictive performance of these scoring systems?
Participants will:
Be assessed using chest trauma scoring systems upon arrival at the emergency department to determine risk levels.
Have demographic and clinical data, including age, gender, injury mechanism, comorbidities, and length of hospital stay, collected to explore potential associations with outcomes.
Eligibility criteria
Qualifiers
Patients diagnosed with blunt chest trauma.
Patients presenting to the emergency department within 4 hours.
Patients (or their legal representatives) must provide informed consent to participate in the study.
Patients who can be assessed using the Chest Trauma Score at the time of arrival (e.g., having stable enough vitals to allow for evaluation).
Disqualifiers
Patients with penetrating chest trauma (e.g., gunshot or stab wounds), as the Chest Trauma Score is typically used for blunt trauma.
Patients presenting with chest conditions unrelated to trauma (e.g., pneumonia, COPD exacerbation, or other non-traumatic causes of chest pain or respiratory distress).
Patients with severe pre-existing comorbidities (e.g., end-stage heart failure, terminal cancer) where trauma is unlikely to be the primary cause of morbidity or mortality.
Patients with missing or incomplete clinical data, including imaging or vital signs necessary to calculate the CTS accurately.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov